REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
für 21.01€ kaufen ··· 134416
··· 10619136
··· REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD[weiter]
Hersteller:
Marke:
EAN:
Kat: 2020/04
Lieferzeit:
Versandkosten:
Icon:
Bild:
14:
15: 1640597706
16: #
17: 0
18: #####
19:
20:
21:
22: #
23: REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
24: REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
25:
5:
6:
7: REGENXBIO Announces Additional Positive Long-term and Interim Phase I/IIa Trial Update for RGX-314 for the Treatment of Wet AMD
::::
2020/04
····
AMD ···· aufgenommen: 19.11.2020 · 08:59:16
···· & überprüft: 27.12.2021 · 10:35:05
:
REGENXBIO :
Announces :
Additional :
Positive :
Interim :
Update :
Treatment :
Preisprotokol